S

Shanghai Henlius Biotech Inc
HKEX:2696

Watchlist Manager
Shanghai Henlius Biotech Inc
HKEX:2696
Watchlist
Price: 20.65 HKD 0.73%
Market Cap: 11.2B HKD
Have any thoughts about
Shanghai Henlius Biotech Inc?
Write Note

Wall Street
Price Targets

Price Targets Summary
Shanghai Henlius Biotech Inc

Wall Street analysts forecast Shanghai Henlius Biotech Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shanghai Henlius Biotech Inc is 22.91 HKD with a low forecast of 20.53 HKD and a high forecast of 25.83 HKD.

Lowest
Price Target
20.53 HKD
1% Downside
Average
Price Target
22.91 HKD
11% Upside
Highest
Price Target
25.83 HKD
25% Upside
Shanghai Henlius Biotech Inc Competitors:
Price Targets
SANA
Sana Biotechnology Inc
414% Upside
603087
Gan & Lee Pharmaceuticals
39% Upside
ARWR
Arrowhead Pharmaceuticals Inc
123% Upside
APLT
Applied Therapeutics Inc
46% Upside
TVTX
Travere Therapeutics Inc
18% Upside
301080
Acrobiosystems Co Ltd
12% Upside
CSL
CSL Ltd
13% Upside
300601
Shenzhen Kangtai Biological Products Co Ltd
4% Upside

Revenue
Forecast

Revenue Estimate
Shanghai Henlius Biotech Inc

For the last 5 years the compound annual growth rate for Shanghai Henlius Biotech Inc's revenue is 274%. The projected CAGR for the next 3 years is 11%.

274%
Past Growth
11%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Shanghai Henlius Biotech Inc

The compound annual growth rate of Shanghai Henlius Biotech Inc's operating income for the next 3 years is 20%.

N/A
Past Growth
20%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Shanghai Henlius Biotech Inc

The compound annual growth rate of Shanghai Henlius Biotech Inc's net income for the next 3 years is 24%.

N/A
Past Growth
24%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shanghai Henlius Biotech Inc's stock price target?
Price Target
22.91 HKD

According to Wall Street analysts, the average 1-year price target for Shanghai Henlius Biotech Inc is 22.91 HKD with a low forecast of 20.53 HKD and a high forecast of 25.83 HKD.

What is Shanghai Henlius Biotech Inc's Revenue forecast?
Projected CAGR
11%

For the last 5 years the compound annual growth rate for Shanghai Henlius Biotech Inc's revenue is 274%. The projected CAGR for the next 3 years is 11%.

What is Shanghai Henlius Biotech Inc's Operating Income forecast?
Projected CAGR
20%

The compound annual growth rate of Shanghai Henlius Biotech Inc's operating income for the next 3 years is 20%.

What is Shanghai Henlius Biotech Inc's Net Income forecast?
Projected CAGR
24%

The compound annual growth rate of Shanghai Henlius Biotech Inc's net income for the next 3 years is 24%.

Back to Top